Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Alcohol Use Disorder and Stress-Related Drinking
NCT07214207Phase 2Recruiting
- Sponsor
- The Ohio State University
- Start
- Dec 2025
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in alcohol use disorder (AUD), sponsored by The Ohio State University. Started Dec 2025; status: recruiting.
02
Drugs
suvorexant
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07214207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214207.